FDA Adverse Event Malfunction Summary report: N

OXFORD TRIAL BEARING MED SZ 3

MDR report key: 7503541 · Received May 10, 2018

Report

Report Number
3002806535-2018-00789
Event Type
Malfunction
Date Received
May 10, 2018
Date of Event
April 16, 2018
Report Date
March 8, 2019
Manufacturer
BIOMET UK LTD.
Product Code
HRY
PMA / PMN Number
PN/A
Removal / Correction Number
N/A
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

ZIMMER BIOMET COMPLAINT (B)(4). THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY ADDITIONAL INFORMATION. PRODUCTS HAVE BEEN RETURNED TO BIOMET UK LTD FOR EVALUATION AND FORWARDED TO THE QUALITY ENGINEER FOR INVESTIGATION. THE DHR FOR THE INVOLVED PRODUCT HAS BEEN REVIEWED AND DOES NOT SHOW ANY NON-CONFORMITY, REJECTION OR CONCESSION THAT COULD BE RELATED TO THE REPORTED EVENT. SOME SCRATCHES WERE FOUND ON THE ARTICULATING SURFACES. DAMAGE TO THE THREAD WAS OBSERVED, WHERE THE HANDLE IS NORMALLY ASSEMBLED. A FRAGMENT WAS MISSING FROM BELOW THE THREADED HOLE, LIKELY DUE TO STRESSES CONCENTRATING IN THE AREA AND CONSEQUENT FATIGUE OVER MULTIPLE USES. CONSIDERING THE FACT THAT THE FRACTURED TRIAL BEARING WAS A PHASE 3 OXFORD PARTIAL KNEE INSTRUMENT, WHICH HAS BEEN COMMERCIALLY AVAILABLE SINCE 1998, FAILURE OF THE COMPONENT COULD BE ASCRIBED TO NORMAL WEAR AND DAMAGE DUE TO USE.

Description of Event or Problem · 0

OXFORD TRIAL BEARING BROKE FROM THE HANDLE.

Additional Manufacturer Narrative · 1

(B)(4). THE INVESTIGATION IS IN PROCESS. ONCE THE INVESTIGATION HAS BEEN COMPLETED, A FOLLOW-UP MDR WILL BE SUBMITTED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE TRIAL BROKE FROM THE HANDLE. THE EVENT OCCURRED DURING SURGERY. THEY USED THERE SECOND TRIAL TO PERFORM THE SURGERY. THERE WAS NO INJURY TO THE PATIENT, BODY OR HEALTH.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
347402 OXFORD TRIAL BEARING MED SZ 3 HRY BIOMET UK LTD. N/A UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1